De-Identified Health Data Market Report 2026

De-Identified Health Data Market Overview

• De-Identified Health Data market size has reached to $9.2 billion in 2025 • Expected to grow to $16.07 billion in 2030 at a compound annual growth rate (CAGR) of 11.7% • Growth Driver: The Rising Adoption Of Electronic Health Records Is Driving The Growth Of The Market Due To Enhanced Patient Care, Secure Data Sharing, And Advanced Analytics • Market Trend: Development In Real-World Biomarker Coverage Applications Driving Evidence-Based Healthcare Insights • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under De-Identified Health Data Market?

De-identified health data refers to patient information from which all personally identifiable details, such as names, addresses, and social security numbers, have been removed, making it impossible to link the data to any individual. It allows healthcare providers, researchers, and organizations to analyze trends, enhance treatments, and design effective public health strategies while protecting patient privacy. The main types of de-identified health data are clinical data, genomic data, patient demographics, prescription data, hospital and provider data, and pharmacogenomic data. Clinical data refers to health-related information about a patient that is collected during the course of healthcare delivery, including medical history, diagnoses, treatments, laboratory results, and outcomes. This service is applied across diverse areas, including clinical research and trials, public health, precision medicine, health economics and outcomes research (HEOR), population health management, drug discovery and development, healthcare quality improvement, insurance underwriting and risk assessment, and others and caters to various end users, including pharmaceutical companies, biotechnology firms, healthcare providers, insurance companies or healthcare payers, research institutions, government agencies, and others.

What Is The De-Identified Health Data Market Growth Forecast?

The de-identified health data market size is expected to see rapid growth in the next few years. It will grow to $16.07 billion in 2030 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to growing use of ai-driven health insights, rising investments in precision medicine research, expansion of value-based care analytics, increasing demand for secure health data exchange, wider adoption of real-world evidence in regulatory decisions. Major trends in the forecast period include expansion of large-scale de-identified data platforms, growing use of real-world evidence analytics, rising demand for privacy-preserving data sharing models, increased adoption of longitudinal patient data analysis, integration of multi-source healthcare datasets.

Global De-Identified Health Data Market Segmentation

1) By Type: Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Hospital And Provider Data, Pharmacogenomic Data 2) By Application: Clinical Research And Trials, Public Health, Precision Medicine, Health Economics And Outcomes Research (HEOR), Population Health Management, Drug Discovery And Development, Healthcare Quality Improvement, Insurance Underwriting And Risk Assessment, Other Applications 3) By End-User: Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies Or Healthcare Payers, Research Institutions, Government Agencies, Other End-Users Subsegments: 1) By Clinical Data: Electronic Health Records, Medical Imaging Data, Laboratory Test Results, Surgical Reports, Pathology Reports, Vital Signs Measurements 2) By Genomic Data: Whole Genome Sequencing Data, Exome Sequencing Data, Single Nucleotide Polymorphism Data, Gene Expression Profiles, Epigenetic Data 3) By Patient Demographics: Age Information, Gender Information, Ethnicity Information, Geographic Location, Socioeconomic Status, Marital Status 4) By Prescription Data: Medication Orders, Dosage Information, Prescription Refill History, Drug Allergies, Pharmacy Dispensation Records 5) By Hospital And Provider Data: Provider Performance Metrics, Care Delivery Outcomes, Billing And Claims Data, Resource Utilization Data 6) By Pharmacogenomic Data: Gene–Drug Interaction Data, Adverse Drug Reaction Data, Personalized Therapy Response Data, Drug Efficacy Variation Data

What Is The Driver Of The De-Identified Health Data Market?

The increasing adoption of electronic health records (EHRs) is expected to propel the growth of the de-identified health data market going forward. Electronic health records (EHR) refer to a digital version of a patient’s comprehensive medical history, including diagnoses, treatments, medications, lab results, and other health information securely stored and shared across authorized healthcare providers. The adoption of electronic health records is increasing due to their ability to enhance patient care and safety through accurate, real-time access to comprehensive medical information. De-identified health data enhances electronic health records by enabling secure data sharing and advanced analytics while protecting patient privacy, ultimately improving clinical decision-making and healthcare outcomes. For instance, in August 2025, according to the National Center for Biotechnology Information, a US-based National Library of Medicine (NLM), which is part of the U.S. National Institutes of Health (NIH) a federal government agency, reported in 2024, most hospitals had adopted patient engagement capabilities that enable patients to electronically view (99%) (e.g., test results), download (96%), and transmit their health information to a third party (84%). Therefore, the rising adoption of electronic health records (EHRs) is driving the growth of the de-identified health data industry.

Key Players In The Global De-Identified Health Data Market

Major companies operating in the de-identified health data market are UnitedHealth Group Incorporated, Oracle Corporation, IQVIA Holdings Inc, ICON Public Limited Company, Datavant Inc, Premier Inc., iMerit Technology Services Pvt. Ltd., Tempus Labs Inc., Medidata Solutions Inc., Veradigm Inc., Flatiron Health, Merative LP, Komodo Health Inc., Shaip Inc., Truveta Inc., Evidation Health Inc., TriNetX Inc., Clarify Health Solutions Inc., Akrivia Health Ltd., Gradient Health Inc.

Global De-Identified Health Data Market Trends and Insights

Major companies operating in the de-identified health data market are focusing on developing advanced solutions, such as real-world biomarker coverage applications, to support evidence-based healthcare decision-making. A real-world biomarker coverage application leverages de-identified patient data to monitor and assess biomarker patterns and effectiveness across diverse populations outside clinical trials, enabling researchers and healthcare providers to gain insights into treatment responses and disease trends. For instance, in July 2025, Datma Inc., a US-based healthcare technology company, launches the Federated Biomarker Explorer, a free application designed for pharmaceutical teams to quickly validate real-world biomarker coverage across Datma’s federated network of participating data contributors. The tool provides aggregate, cohort-level insights into biomarker presence, enabling teams to assess coverage quickly without the need for contracts or IT support. It also allows secure integration of users’ own data for overlap analysis and facilitates early-stage feasibility assessments with clinical and demographic filtering, helping validate whether datasets include the necessary patient populations before committing resources.

What Are Latest Mergers And Acquisitions In The De-Identified Health Data Market?

In July 2025, Datavant Inc., a US-based health information technology company, acquired Aetion Inc. for an undisclosed amount. Through this acquisition, Datavant aims to enhance its real-world evidence (RWE) capabilities by integrating Aetion's advanced analytics platform, thereby offering life sciences and healthcare organizations an end-to-end solution for generating regulatory-grade insights from de-identified health data. Aetion, Inc., is a US-based real-world evidence (RWE) platform that offers de-identified health data services through platforms such as Aetion Generate.

Regional Outlook

North America was the largest region in the de-identified health data market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the De-Identified Health Data Market?

The de-identified health data market includes revenues earned by entities by providing services such as medical research and clinical studies, machine learning development, public health and epidemiology, healthcare system improvement, and health economics and policy planning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the De-Identified Health Data Market Report 2026?

The de-identified health data market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the de-identified health data industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.